The reduction of serum soluble Flt-1 in patients with neovascular age-related macular degeneration

scientific article

The reduction of serum soluble Flt-1 in patients with neovascular age-related macular degeneration is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.AJO.2014.09.036
P932PMC publication ID4262635
P698PubMed publication ID25284761

P50authorUsha ChakravarthyQ54263391
Ruth HoggQ56256992
P2093author name stringBalamurali K Ambati
Hironori Uehara
Molly McFadden
Michael Taggart
Christina Mamalis
Brian Stagg
Phillip Earle
Samuel Passi
P2860cites workComplement factor H polymorphism in age-related macular degenerationQ24553334
Vascular endothelial growth factor plasma levels before and after treatment of neovascular age-related macular degeneration with bevacizumab or ranibizumabQ61758502
Fifteen-Year Cumulative Incidence of Age-Related Macular DegenerationQ64461527
Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokersQ73121134
Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritisQ73601063
Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokersQ81638207
Changes in blood oxidative and antioxidant parameters in a group of Chinese patients with age-related macular degenerationQ83761863
Genetic and environmental risk factors for age-related macular degeneration in persons 90 years and olderQ87372836
Complement factor H variant increases the risk of age-related macular degenerationQ28239239
HTRA1 promoter polymorphism in wet age-related macular degenerationQ28269561
Corneal avascularity is due to soluble VEGF receptor-1Q28755125
Seven new loci associated with age-related macular degenerationQ29416998
Complement factor H polymorphism and age-related macular degenerationQ29614931
Prevalence of age-related macular degeneration in the United StatesQ29614964
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in womenQ29616306
Smoking and age-related macular degeneration: a review of association.Q34449581
A variant of the HTRA1 gene increases susceptibility to age-related macular degenerationQ34575452
Serum Lipid Biomarkers and Hepatic Lipase Gene Associations with Age-Related Macular DegenerationQ34847083
The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis).Q35676416
Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritisQ35840268
Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesisQ36604482
Vascular endothelial growth factor A polymorphisms and age-related macular degeneration: a systematic review and meta-analysisQ36908876
Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1.Q36942442
Carotenoids and co-antioxidants in age-related maculopathy: design and methods.Q37344249
Superoxide dismutase1 levels in North Indian population with age-related macular degenerationQ37394541
Effect of soluble inducible costimulator level and its polymorphisms on age-related macular degenerationQ37395270
Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) studyQ37570185
A review and meta-analysis of the association between C-reactive protein and age-related macular degenerationQ37855164
Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.Q39288785
New biomarker for neovascular age-related macular degeneration: eotaxin-2.Q39544638
An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study GroupQ40440695
The Wisconsin age-related maculopathy grading systemQ41902806
Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degenerationQ42953147
Predictive model for earlier diagnosis of suspected age-related macular degeneration patients.Q45941229
Intravitreal injection of ranibizumab for treatment of age-related macular degeneration: effects on serum VEGF concentrationQ46194066
Causes and prevalence of visual impairment among adults in the United StatesQ46890945
Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularizationQ46937245
Association between C-reactive protein and age-related macular degeneration.Q51051730
A study on plasma homocysteine level in age-related macular degeneration.Q51332108
Single nucleotide polymorphism and serum levels of VEGFR2 are associated with age related macular degeneration.Q54480133
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectmacular degenerationQ27429789
P304page(s)92-100.e1-2
P577publication date2014-10-18
P1433published inAmerican Journal of OphthalmologyQ4744258
P1476titleThe reduction of serum soluble Flt-1 in patients with neovascular age-related macular degeneration
P478volume159

Reverse relations

cites work (P2860)
Q39260919Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy
Q33681908Decreased Circulating Levels of Dickkopf-1 in Patients with Exudative Age-related Macular Degeneration
Q47741873Evaluation of sFLT1 protein levels in human eyes with the FLT1 rs9943922 polymorphism
Q64900966Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis.
Q37510227Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration
Q52558418Positive and Negative Regulation of Angiogenesis by Soluble Vascular Endothelial Growth Factor Receptor-1.
Q95803127Post-Vitrectomy Endophthalmitis in Victoria, Australia
Q52728564RNA activating-double stranded RNA targeting flt-1 promoter inhibits endothelial cell proliferation through soluble FLT-1 upregulation.
Q38828895Risk factors and biomarkers of age-related macular degeneration
Q36858963Serum vascular endothelial growth factor receptor-2 and adropin levels in age-related macular degeneration
Q33727486Targeted Delivery of FLT-Morpholino Using Cyclic RGD Peptide
Q38761425The Pathway From Genes to Gene Therapy in Glaucoma: A Review of Possibilities for Using Genes as Glaucoma Drugs

Search more.